NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

EVH | NYSE

$4.87 $0.14 | 2.96%
TREND SIGNAL:Signal available — unlock to view |2026-10-13

Company Overview:

Market Cap: $548.08M
Trailing PE: N/A
FWD PE *: 14.5x
Payout Ratio (TTM): —
52-Week Range: $2.10 - $8.30

* Forward PE is based on street estimates.

10 Year EVH Performance Metrics:

Total Return (with DRIP): -78.6% (-14.29% CAGR)
Total Return (no DRIP): -78.6% (-14.29% CAGR)
Share Price: -78.6% (-14.29% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $2,141
Total Return $ (with DRIP): -$7,859
EVH Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
EVH Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

EVH Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

EVH - Revenue
EVH Revenue CAGR:1Y: 46.86%2Y: 0.41%5Y: 24.06%10Y: 27.71%
EVH - Earnings Per Share (EPS)
EVH EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Net Income
EVH Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - EBITDA
EVH EBITDA CAGR:1Y: -36.01%2Y: -48.08%5Y: -4.26%10Y: 0.00%
EVH - Free Cash Flow
EVH Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Free Cash Flow / Share
EVH Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Operating Income
EVH Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Gross Profit
EVH Gross Profit CAGR:1Y: 5.06%2Y: -13.02%5Y: 10.11%10Y: 13.04%
EVH - Shares Outstanding
EVH Shares Outstanding CAGR:1Y: -2.88%2Y: -0.94%5Y: 5.66%10Y: 10.20%
EVH - Share Buybacks
EVH Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Stock-Based Comp
EVH Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 12.43%
EVH - Expenses
EVH Expenses CAGR:1Y: 51.14%2Y: 36.58%5Y: 18.93%10Y: 12.99%
EVH - Revenue by Segment
EVH Revenue CAGR:1Y: 46.86%2Y: 0.41%5Y: 24.06%10Y: 27.71%
EVH - Revenue by Region
EVH Revenue CAGR:1Y: 46.86%2Y: 0.41%5Y: 24.06%10Y: 27.71%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

EVH - REVENUE: Actual + Estimates
EVH Actual Revenue CAGR:1Y: 46.86%2Y: 0.41%5Y: 24.06%10Y: 27.71%
EVH - EPS: Actual + Estimates
EVH Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - NET INCOME: Actual + Estimates
EVH Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - EBITDA: Actual + Estimates
EVH Actual EBITDA CAGR:1Y: -36.01%2Y: -48.08%5Y: -4.26%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

EVH - Net Profit Margin
EVH Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Gross Profit Margin
EVH Gross Profit Margin CAGR:1Y: -28.46%2Y: -13.37%5Y: -11.24%10Y: -11.49%
EVH - Price to Earnings
EVH Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Price To Sales Ratio
EVH Price To Sales Ratio CAGR:1Y: -68.17%2Y: -46.47%5Y: -35.11%10Y: -23.84%
EVH - Return on Capital Employed
EVH Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EVH - Return on Invested Capital
EVH Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for EVH

Based on past 10-year performance, here are EVH growth metrics:

Share price CAGR of -14.75%
Dividend CAGR of +0%

Using EVH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

EVH (DRIP)EVH - No DRIP
Current Price$4.87$4.87
Start Shares2,053.392,053.39
Start Value$10,000$10,000
  
After 10 years:
Final Share Count2,053.392,053.39
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$0.99$4.87
Total Dividends$0$0
Final Value$2,028$10,000

Estimated Future Value + Dividends - EVH

NOTE: Above numbers are our estimate based on EVH's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Evolent Health, Inc. (EVH) had its IPO on 2015-06-05, and is traded on NYSE stock exchange.

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

EVH website: https://www.evolent.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — EVH

Value from:
Pay up to today
—
vs current price $4.87
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →